Please login to the form below

biopharma

This page shows the latest biopharma news and features for those working in and with pharma, biotech and healthcare.

Healthcare Comms news

The work, which was for US biopharma Amgen, told the story of the impact of BiTE antibodies on the engagement of T cells with cancer cells, and was directed by

Latest news

May’s Brexit plan cautiously welcomed by biopharma sector

May’ s Brexit plan cautiously welcomed by biopharma sector. The white paper says the UK should adhere to EMA regulations post-Brexit. ... For the Association of the British Pharma Industry (ABPI) and BioIndustry Association (BIA), the white paper
Daily Brief: Novartis exits anti-infectives drive, Hancock takes over from Hunt and Trump attacks 'soft Brexit' plan

Read more: May’s Brexit plan cautiously welcomed by biopharma sector.
VC raises new €270m fund for European biotechs

With a surge of M&A deals involving biotech companies and big biopharma players already this year after a relatively quiet 2017, VC investors are seeing more opportunity to make money
Axovant licenses another gene therapy as new strategy beds in

Axovant licenses another gene therapy as new strategy beds in. Pays Benitec Biopharma $10m upfront for six projects. ... The latest deal with Benitec Biopharma gives the Roivant Sciences company global rights to a preclinical stage gene therapy for rare
CTI slumps as Servier-partnered lymphoma drug fails

CTI BioPharma has been poleaxed by the news that its much-anticipated late-stage trial for Pixuvri in non-Hodgkin’s lymphoma (NHL) has ended in failure.

More from news
Approximately 10 fully matching, plus 416 partially matching documents found.

Latest Intelligence

Diversity and inclusion in the pharma industry

biopharma industry is one of the most powerful and important industries today, directly affecting the lives of billions of people around the world on a daily basis.
How can pharma build bridges with HCPs online?

What is holding pharma back? As referenced in the report, the highly regulated environment in which pharma and biopharma companies operate is partly to blame for their failure to harness the
Accelerating diagnosis in rare disease

Timely diagnosis in rare disease is one of the fundamental unmet needs for patients, healthcare professionals (HCPs) and biopharma.
Accelerating diagnosis in rare disease

Accelerating diagnosis in rare disease. Timely diagnosis in rare disease is one of the fundamental unmet needs for patients, healthcare professionals (HCPs) and biopharma.
Communication is the key to the participatory medicine model

Healthcare systems are in need of external support to speed-up best practice adoption, with biopharma ideally placed to assist. ... Biopharma can play a key role in providing training for physicians that coaches them on optimal patient communication

More from intelligence
Approximately 0 fully matching, plus 63 partially matching documents found.

Latest appointments

Weekly industry appointments

Here you will find a recent selection of movers within pharma, biopharma, biotech and CMOs.
Axovant poaches Allergan’s and Teva’s chief medical and science officers

Gavin Corcoran and Michael Hayden join the biopharma. Clinical stage biopharmaceutical group Axovant has appointed Gavin Corcoran as its new executive vice president of research and development.
Abeona Therapeutics appoints new additions to board of directors

Abeona Therapeutics appoints new additions to board of directors. Stefano Buono and Richard Van Duyne join the biopharma.
Pharnext appoints COO

Pharnext appoints COO. Amit Kohli joins the biopharma from Eurofins. Clinical-stage biopharmaceutical group Pharnext has appointed Amit Kohli as its new chief operating officer, a role which will see him
Neurimmune appoints chief business officer

Neurimmune appoints chief business officer. Fabian Buller will further drive the biopharma’s growth strategy.

More from appointments
Approximately 8 fully matching, plus 133 partially matching documents found.

Latest from PMHub

Training the next generation of biotech leaders

biopharma. He is also coordinating outreach activities with school children to inspire future generations of biochemical engineers.
Immunotherapies in oncology: the future of cancer treatment lies in combinations and partnerships

Immunotherapies in oncology: the future of cancer treatment lies in combinations and partnerships. Anne Legendre reviews the scientific rationale behind immunotherapy combinations and Frances Hendry examines how partnerships, co-marketing and
Preparing for biopharma marketing in 2020 and beyond - Who is the marketer of the future?

Preparing for biopharma marketing in 2020 and beyond - Who is the marketer of the future? ... Who is the Marketer of the Future? Preparing for Biopharma Marketing in 2020 and Beyond.
Delivering on what matters to patients

there when I need you?” In other words, are biopharma companies really present in ways that truly matter to patients and in places where patients want them to be? ... If the statement “ Not everything that matters can be measured, and not everything
White paper download: Creating a patient-led brand strategy

To survive in an increasingly competitive marketplace, biopharma companies need to create strong, patient-centric brands that differentiate themselves from their competitors and convince the payer, physician and patient of their

More from PMHub
Approximately 1 fully matching, plus 18 partially matching documents found.

Featured jobs

Principal Medical Writer / Editorial Director – Medical Communic...: £60, 000 - £80, 000

Home based, Chief Medical Writer, Medical Communications: Excellent package

Business Unit Head, Medical Communications, London: Excellent package

Scientific Communications Director - Oncology – In House Pharma ...: Neg

Account Manager, Medical Communications and Marketing: £30, 000 – £40, 000 benefits and bonus

Head of Market Access - International - Based Cambridge: Excellent Basic, Bonus and Flex Benefits

Account Director, Medical Communications: C£50 – 65, 000 benefits and bonus

Senior Medical Writer, Healthcare Advertising Agency: £45, 000 – £50, 000

Delivery Manager/ Head of Delivery – Executive Search: Neg

Client Services Director – Healthcare Advertising - London: Neg

Account Manager: £40, 000 - £45, 000 benefits

Senior Account Manager: Competitive salary commensurate with experience

Client Services Director - Med Comms: Great salary and bebefits

Account Director, Consumer Healthcare PR, Global PR agency: £50, 000 – £58, 000

Editorial Director – Medical Education (MedComms): Neg

Home based, Principal Medical Writer, Medical Communications: Excellent package

Strategic Planner, Healthcare Advertising: £47, 000 – £53, 000

Healthcare PR Director: £100, 000 – £120, 000 benefits

Senior Project Manager - Medical Writing: Great salary and bebefits

Home based, Senior Medical Writer, Medical Communications: Excellent package

Home based, Editorial Team Leader, Medical Communications: Excellent package

Subscribe to our email news alerts

PMHub

Add my company

EY Life Sciences

Our global reach Against a backdrop of regulatory, digital, financial and global transformation, Life Sciences companies are finding integration and...